Science Explorer Back to mapMap
Discussion
Researcher · Phio Pharmaceuticals (United States) · United States

Benjamin Cuiffo

Benjamin Cuiffo publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as CAR-T cell therapy research, Immunotherapy and Immune Responses and Protein Degradation and Inhibitors.

ORCID 0000-0002-9477-7317 OpenAlex
World rank
#1,523,539
of 7,710,434 ranked researchers
Rank in United States
#476,608
of 1,627,098
Works
47
Citations
1.4k
Citations per work
29.2
h-index
11
i10-index 11Top 71% in Molecular Biology
Benjamin Cuiffo

What does Benjamin Cuiffo research?

Benjamin Cuiffo's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Medicine (23%), Immunology and Microbiology (11%).

Life Sciences: 22 works · 47.8% of their workBiochemistry, Genetics and Molecular Biology: 17 works · 36.8% of their workMolecular Biology: 15 works · 30.9% of their workCancer Research: 3 works · 5.9% of their workImmunology and Microbiology: 5 works · 11.0% of their workImmunology: 5 works · 11.0% of their workHealth Sciences: 11 works · 22.8% of their workMedicine: 11 works · 22.8% of their workOncology: 8 works · 16.2% of their workHematology: 3 works · 6.6% of their workEverything else: 11 works · 22.8% of their workPhysical Sciences: 3 works · 6.6% of their workEngineering: 3 works · 6.6% of their workBiomedical Engineering: 3 works · 6.6% of their workTHEIR WORKBenjamin Cuiffo47works
Life Sciences48%Physical Sciences7%Health Sciences23%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1736.8%
    2. Immunology and Microbiology511.0%
    1. Medicine1122.8%
  3. Everything else1122.8%
    1. Engineering36.6%
  1. 1Molecular Biology31% of their works
  2. 2Oncology16% of their works
  3. 3Immunology11% of their works
  4. 4Biomedical Engineering7% of their works
  5. 5Hematology7% of their works
  6. 6Cancer Research6% of their works

Research topics

Which keywords describe Benjamin Cuiffo's research?

The keywords of their largest research topics: Immunotherapy, Cancer Immunotherapy, Tumor Regression, Tumor Targeting, CAR T Cells, Chimeric Antigen Receptor, Dendritic Cells and Gene Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Immunotherapy263 topics
  2. Cancer Immunotherapy232 topics
  3. Tumor Regression182 topics
  4. Tumor Targeting142 topics
  5. CAR T Cells121 topic
  6. Chimeric Antigen Receptor121 topic
  7. Dendritic Cells111 topic
  8. Gene Therapy112 topics
  9. Immunity111 topic
  10. BET Bromodomains91 topic
  11. PROTACs91 topic
  12. Nanoparticles81 topic
  13. Photothermal Therapy81 topic
  14. Arginine Deprivation61 topic
  15. Bacterial Therapy61 topic
  16. Immune Checkpoint Blockade51 topic
  17. PD-1 and PD-L151 topic
  18. RNA Interference51 topic
  19. siRNA Delivery51 topic
  20. Gene Expression41 topic
  21. MicroRNA41 topic

Where does Benjamin Cuiffo work?

Benjamin Cuiffo's main affiliation in the publication record is Phio Pharmaceuticals (United States), United States.

How many publications and citations does Benjamin Cuiffo have?

OpenAlex counts 47 works and 1,372 citations for Benjamin Cuiffo, an h-index of 11, ranking #1,523,539 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Benjamin Cuiffo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.